ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,770Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 2588

$1.26M Total Retail Price of All Prescriptions

Rank: 48 out of 2588

702 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

24% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 20,441 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 944 824 1 5
SIMVASTATIN 928 776 2 1
LEVOTHYROXINE SODIUM 812 657 3 2
LISINOPRIL 694 599 4 3
OMEPRAZOLE 645 472 5 6
HYDROCODONE-ACETAMINOPHEN 617 479 S3 6 7
AMLODIPINE BESYLATE 521 480 7 4
METOPROLOL TARTRATE 511 432 8 9
POTASSIUM CHLORIDE 498 427 9 15
HYDROCHLOROTHIAZIDE 484 433 10 13
SPIRONOLACTONE 431 374 11 58
PAROXETINE HCL 429 384 12 71
WARFARIN SODIUM 414 387 13 10
DONEPEZIL HCL 353 319 14 22
ATENOLOL 349 340 15 14
ATORVASTATIN CALCIUM 332 283 16 11
METOPROLOL SUCCINATE 296 229 17 12
PREDNISONE 283 257 18 42
METFORMIN HCL 279 206 19 8
POLYETHYLENE GLYCOL 3350 269 221 20 55
ALENDRONATE SODIUM 268 241 21 21
TAMSULOSIN HCL 265 188 22 23
KLOR-CON M20 263 221 23 52
MELOXICAM 263 232 23 51
ALLOPURINOL 260 241 25 33
PRAVASTATIN SODIUM 258 231 26 16
RISPERIDONE 254 147 27 57
CITALOPRAM HBR 247 165 28 27
GABAPENTIN 245 138 29 18
CEFUROXIME 233 196 30 183
RANITIDINE HCL 232 163 31 37
TRAZODONE HCL 221 154 32 61
NAMENDA 218 173 33 32
MIRTAZAPINE 191 154 34 63
CEPHALEXIN 179 152 35 138
FENTANYL 178 125 S2 36 78
NEXIUM 168 86 37 41
LOSARTAN POTASSIUM 165 161 38 17
CLOPIDOGREL 163 143 39 30
DIGOXIN 161 161 40 38
FLUTICASONE PROPIONATE 159 124 41 40
CARVEDILOL 156 135 42 20
AZITHROMYCIN 155 131 43 45
SERTRALINE HCL 153 96 44 26
QUETIAPINE FUMARATE 148 101 45 74
LAMOTRIGINE 146 67 46 170
TRIAMCINOLONE ACETONIDE 144 107 47 106
GLYBURIDE 142 118 R 48 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 114 49 35
PRAMIPEXOLE DIHYDROCHLORIDE 139 111 49 188
ACETAMINOPHEN-CODEINE 135 124 S3 51 80
LANTUS 130 88 52 47
CARBIDOPA-LEVODOPA 126 98 53 83
TRIAMTERENE-HCTZ 126 102 53 46
ZETIA 123 118 55 69
CYMBALTA 120 57 56 70
CIPROFLOXACIN HCL 117 97 57 82
OXYBUTYNIN CHLORIDE ER 116 94 58 85
FLUOXETINE HCL 115 58 59 92
ISOSORBIDE MONONITRATE ER 113 103 60 49
PLAVIX 112 100 61 43
CRESTOR 110 92 62 25
CLONIDINE HCL 110 91 62 54
FAMOTIDINE 109 88 64 36
VENLAFAXINE HCL ER 109 71 64 125
SUCRALFATE 108 77 66 193
DIVALPROEX SODIUM 108 48 66 89
ZOLPIDEM TARTRATE 106 99 68 24
DIOVAN 105 103 69 29
TRAMADOL HCL 103 76 70 19
ROPINIROLE HCL 100 74 71 113
PROAIR HFA 100 51 71 50
OLANZAPINE 99 45 73 126
KLOR-CON M10 98 51 74 139
NABUMETONE 96 64 75 147
PANTOPRAZOLE SODIUM 93 70 76 28
OXYBUTYNIN CHLORIDE 91 88 77 132
GLIPIZIDE 91 86 77 44
LEVETIRACETAM 89 24 79 90
ENALAPRIL MALEATE 85 61 80 31
CARBAMAZEPINE 85 12 80 146
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 54 80 127
AMITRIPTYLINE HCL 83 67 R 83 91
KLOR-CON 10 81 78 84 75
DILTIAZEM 24HR CD 80 59 85 98
FELODIPINE ER 78 76 86 108
GLIMEPIRIDE 77 64 87 39
LEVOFLOXACIN 72 61 88 77
PHENYTOIN SODIUM EXTENDED 72 59 88 109
DOXYCYCLINE HYCLATE 72 58 88 151
ADVAIR DISKUS 71 50 91 48
GENTAMICIN SULFATE 68 53 92 359
LANSOPRAZOLE 67 67 93 157
IBUPROFEN 67 26 93 62
NITROGLYCERIN PATCH 65 65 95 149
AMLODIPINE BESYLATE-BENAZEPRIL 62 62 96 76
GLIPIZIDE ER 62 49 96 73
DILTIAZEM ER 61 61 98 150
BACLOFEN 60 13 99 142
LITHIUM CARBONATE 59 53 100 229
GEMFIBROZIL 56 56 101 123
LANTUS SOLOSTAR 55 55 102 93
MEGESTROL ACETATE 54 48 R 103 169
SYNTHROID 53 53 104 88
PREMARIN 53 27 R 104 247
DIVALPROEX SODIUM ER 52 29 106 121
LOVASTATIN 52 52 106 34
DIOVAN HCT 52 52 106 72
INSULIN SYRINGE 51 33 109 81
METOCLOPRAMIDE HCL 50 13 110 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.